Awakn Life Sciences Corp. (AWKNF)
USD 0.07
(-18.75%)
USD 0.07
(-18.75%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 2.07 Million CAD | -53.33% |
| 2023 | 4.44 Million CAD | 15.31% |
| 2022 | 3.85 Million CAD | 969.04% |
| 2021 | 360.44 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 2.03 Million CAD | 0.91% |
| 2024 Q4 | 2.07 Million CAD | 1.71% |
| 2024 Q2 | 2.02 Million CAD | -61.07% |
| 2024 FY | 2.07 Million CAD | -53.33% |
| 2024 Q1 | 5.18 Million CAD | 16.79% |
| 2023 Q4 | 4.44 Million CAD | -4.67% |
| 2023 FY | 4.44 Million CAD | 15.31% |
| 2023 Q3 | 4.66 Million CAD | 26.43% |
| 2023 Q2 | 3.68 Million CAD | -10.46% |
| 2023 Q1 | 4.11 Million CAD | 6.85% |
| 2022 Q2 | 944.31 Thousand CAD | -77.34% |
| 2022 FY | 3.85 Million CAD | 969.04% |
| 2022 Q1 | 4.16 Million CAD | 1056.07% |
| 2022 Q3 | 4.12 Million CAD | 337.32% |
| 2022 Q4 | 3.85 Million CAD | -6.69% |
| 2021 Q4 | 360.44 Thousand CAD | 0.0% |
| 2021 FY | 360.44 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Bioxytran, Inc. | 3.24 Million USD | 36.186% |
| Eiger BioPharmaceuticals, Inc. | 53.3 Million USD | 96.11% |
| Institute of Biomedical Research Corp. | 421.56 Thousand USD | -391.886% |
| SQZ Biotechnologies Company | 50.03 Million USD | 95.856% |
| Intellipharmaceutics International Inc. | 12 Million USD | 82.732% |
| Evofem Biosciences, Inc. | 72.47 Million USD | 97.139% |
| Santhera Pharmaceuticals Holding AG | 59.01 Million USD | 96.486% |
| Propanc Biopharma, Inc. | 3.85 Million USD | 46.159% |
| Marizyme, Inc. | 26.67 Million USD | 92.227% |
| Genus plc | 485 Million USD | 99.572% |
| Pharming Group N.V. | 244.07 Million USD | 99.15% |
| Therapeutic Solutions International, Inc. | 2.01 Million USD | -3.159% |
| CNBX Pharmaceuticals Inc. | 2.51 Million USD | 17.593% |
| Nymox Pharmaceutical Corporation | 3.8 Million USD | 45.431% |
| ContraFect Corporation | 32.53 Million USD | 93.626% |
| RegeneRx Biopharmaceuticals, Inc. | 3.82 Million USD | 45.825% |
| IMV Inc. | 37.93 Million USD | 94.533% |
| AXIM Biotechnologies, Inc. | 11.77 Million USD | 82.394% |
| ONE Bio Corp. | 27.49 Million USD | 92.458% |
| RVL Pharmaceuticals plc | 77.41 Million USD | 97.321% |
| Mesoblast Limited | 188.44 Million USD | 98.9% |
| MultiCell Technologies, Inc. | 1617.67 USD | -128086.528% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 82.93 Million USD | 97.5% |
| Genscript Biotech Corporation | 1.32 Billion USD | 99.844% |
| Neon Bloom, Inc. | 1.22 Million USD | -69.109% |
| Mosaic ImmunoEngineering Inc. | 5.14 Million USD | 59.704% |
| Nanobac Pharmaceuticals, Incorporated | 9.58 Million USD | 78.359% |
| Biomind Labs Inc. | 1.49 Million USD | -38.37% |
| Provectus Biopharmaceuticals, Inc. | 9.04 Million USD | 77.067% |
| Oncotelic Therapeutics, Inc. | 18.4 Million USD | 88.732% |
| Skye Bioscience, Inc. | 14.07 Million USD | 85.264% |
| GlobeStar Therapeutics Corporation | 1.43 Million USD | -44.619% |
| VioQuest Pharmaceuticals, Inc. | 5.84 Million USD | 64.508% |
| THC Farmaceuticals, Inc. | 142.09 Thousand USD | -1359.33% |
| PsyBio Therapeutics Corp. | 1.98 Million USD | -4.66% |
| Arch Therapeutics, Inc. | 9.46 Million USD | 78.094% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 201.11 Thousand USD | -931.064% |
| Accustem Sciences Inc. | 1.07 Million USD | -92.139% |
| EV Biologics, Inc. | 2.11 Million USD | 1.959% |
| Q BioMed Inc. | 8.13 Million USD | 74.503% |
| GB Sciences, Inc. | 5.41 Million USD | 61.724% |
| Alpha Cognition Inc. | 7.16 Million USD | 71.058% |
| CSL Limited | 18.62 Billion USD | 99.989% |
| Agentix Corp. | 2.51 Million USD | 17.403% |
| American Oriental Bioengineering, Inc. | 118.72 Million USD | 98.253% |
| Enzolytics Inc. | 365.26 Million USD | 99.432% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Resverlogix Corp. | 67.39 Million USD | 96.923% |
| Nuo Therapeutics, Inc. | 838.73 Thousand USD | -147.235% |
| MetaStat, Inc. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | 5.74 Million USD | 63.911% |
| argenx SE | 444.95 Million USD | 99.534% |
| Northwest Biotherapeutics, Inc. | 74.92 Million USD | 97.232% |
| HST Global, Inc. | 593.59 Thousand USD | -249.336% |
| Enzon Pharmaceuticals, Inc. | 1.71 Million USD | -20.982% |
| Wesana Health Holdings Inc. | 1.25 Million USD | -64.68% |
| Halberd Corporation | 728.71 Thousand USD | -184.559% |
| Endonovo Therapeutics, Inc. | 24.74 Million USD | 91.62% |
| Inhibitor Therapeutics, Inc. | 3.66 Million USD | 43.423% |
| Zenith Capital Corp. | 27.56 Thousand USD | -7421.618% |
| RespireRx Pharmaceuticals Inc. | 11.9 Million USD | 82.579% |
| GeneThera, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 3.73 Million USD | 44.471% |
| AVAX Technologies, Inc. | 3.99 Million USD | 48.078% |
| WPD Pharmaceuticals Inc. | 680.83 Thousand USD | -204.573% |
| Cotinga Pharmaceuticals Inc. | 2.71 Million USD | 23.528% |
| Ember Therapeutics, Inc. | 238.65 Thousand USD | -768.888% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | 7.86 Million USD | 73.62% |
| Helix BioMedix, Inc. | 66.92 Thousand USD | -2998.261% |
| Capstone Therapeutics Corp. | 50.26 Million USD | 95.875% |
| Kadimastem Ltd | 3.5 Million USD | 40.836% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 15.9 Million USD | 86.962% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 464.69 Thousand USD | -346.232% |
| Burzynski Research Institute, Inc. | 27.43 Thousand USD | -7458.907% |
| LadRx Corporation | 2.2 Million USD | 5.766% |
| Cell Source, Inc. | 15.8 Million USD | 86.881% |
| ProtoKinetix, Incorporated | 44.69 Thousand USD | -4539.42% |
| Regen BioPharma, Inc. | 5.45 Million USD | 62.005% |
| Regen BioPharma, Inc. | 5.45 Million USD | 62.005% |
| Affymax, Inc. | 8.87 Million USD | 76.625% |
| Mobile Lads Corp. | 1.31 Million USD | -57.871% |
| Itoco Inc. | 1.65 Million USD | -25.435% |
| Rasna Therapeutics, Inc. | 2.05 Million USD | -1.076% |
| Pathfinder Cell Therapy, Inc. | 6.04 Million USD | 65.719% |
| International Stem Cell Corporation | 5.27 Million USD | 60.704% |
| CytoDyn Inc. | 127.89 Million USD | 98.379% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 41.79 Thousand USD | -4860.968% |
| NanoSphere Health Sciences Inc. | 1.56 Million USD | -32.384% |
| Qrons Inc. | 1.48 Million USD | -39.29% |
| Alseres Pharmaceuticals, Inc. | 11.04 Million USD | 81.226% |
| SYBLEU INC | 681.41 Thousand USD | -204.314% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 808.79 Thousand USD | -156.386% |
| Rebus Holdings, Inc. | 5.24 Million USD | 60.442% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 6.1 Million USD | 66.017% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 625.8 Thousand USD | -231.353% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 4.61 Million USD | 55.088% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 40.99 Million USD | 94.942% |
| Adhera Therapeutics, Inc. | 22.26 Million USD | 90.687% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 2.02 Million USD | -2.382% |
| Innovation Pharmaceuticals Inc. | 5.47 Million USD | 62.146% |
| Neutra Corp. | 973.52 Thousand USD | -113.002% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | 92.853% |
| PureTech Health plc | 125.58 Million USD | 98.349% |
| Coeptis Therapeutics, Inc. | 3.75 Million USD | 44.808% |
| IXICO plc | 1.9 Million USD | -9.122% |
| IntelGenx Technologies Corp. | 20.52 Million USD | 89.899% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 97.993% |
| CSL Limited | 18.62 Billion USD | 99.989% |
| Cellectis S.A. | 249.36 Million USD | 99.168% |